| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/03/2009 | US7485299 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/03/2009 | US7485297 Method of inhibition of vascular development using an antibody |
| 02/03/2009 | US7485296 Using monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis and treatment of cell proliferfative disorders; immunodiagnostics; immunotherapy |
| 02/03/2009 | US7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 02/03/2009 | CA2237817C Increasing the fvii sensitivity of a thromboplastin reagent |
| 02/03/2009 | CA2223567C Modified meningococcal polysaccharide conjugate vaccines |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 02/03/2009 | CA2152066C Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 02/03/2009 | CA2150925C Improved synthesis of polymer bio-active conjugates |
| 01/29/2009 | WO2009014745A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | WO2009014744A1 Methods and compositions for treating autoimmune disease |
| 01/29/2009 | WO2009014476A1 Method and means for prediction of systemic lupus erythematosus susceptibility |
| 01/29/2009 | WO2009014456A1 Materials and methods for sperm sex selection |
| 01/29/2009 | WO2009014216A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 01/29/2009 | WO2009014207A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | WO2009013619A2 The ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 01/29/2009 | WO2009013484A1 Immune modulation via c-type lectin |
| 01/29/2009 | WO2009013097A1 Complexes of grp94 with human immunoglobulin g |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008156763A3 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
| 01/29/2009 | WO2008145140A3 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals |
| 01/29/2009 | WO2008138536A3 Antibody directed to g protein coupled receptors (gpcr) |
| 01/29/2009 | WO2008131575A3 Anti-alk antibodies suitable for treating metastatic cancers or tumors |
| 01/29/2009 | WO2008127680A3 Diagnosis and treatment of diseases caused by misfolded proteins |
| 01/29/2009 | WO2008122441A3 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/29/2009 | WO2008101177A3 Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis |
| 01/29/2009 | WO2008085938A3 Antibody inhibiting infection of papillomavirus |
| 01/29/2009 | WO2008055242A4 Early detection of diabetes |
| 01/29/2009 | WO2008022152A3 Optimized antibodies that target cd19 |
| 01/29/2009 | WO2008010101A9 Antagonist antibody against epha2 for the treatment of cancer |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | WO2007027957A3 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 01/29/2009 | US20090031445 Methods to enhance plant trauma resistance |
| 01/29/2009 | US20090031444 Homologous recombination in plants |
| 01/29/2009 | US20090031441 Regulatory Genes for Plant Differentiation and Growth, and Use of the Same |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030187 free of a denaturing reagent and comprising of an antibody that binds to a respiratory syncytial virus (RSV) antigen, a human metapneumovirus (hMPV) antigen, integrin alpha v beta 3, CD2, CD19, an Eph receptor, or to IL-9 |
| 01/29/2009 | US20090030186 Pichia methanolica secretory signal |
| 01/29/2009 | US20090029916 Fibroblast Growth Factor-14 |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029484 Novel Hemopoietin Receptor Protein, NR12 |
| 01/29/2009 | US20090029460 Neoplasm-specific polypeptides and their uses |
| 01/29/2009 | US20090029456 STR50 and uses thereof |
| 01/29/2009 | US20090029455 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 01/29/2009 | US20090029439 Regeneration |
| 01/29/2009 | US20090029438 Composite materials comprising supported porous gels |
| 01/29/2009 | US20090029426 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
| 01/29/2009 | US20090029419 Expression of modified antibodies in avian cells |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029405 Large stoke shift nir dyes |
| 01/29/2009 | US20090029396 Assay kit and antibody for human low molecular weight CD14 |
| 01/29/2009 | US20090029393 Method for preparing antibodies selective for activating fc receptors |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029371 Method for determining vasoreactivity |
| 01/29/2009 | US20090029358 Methods and Compositions for the Diagnosis and Treatment of Schizophrenia |
| 01/29/2009 | US20090029355 Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease |
| 01/29/2009 | US20090028892 Ostertagia Vaccine |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028881 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 01/29/2009 | US20090028880 Serum albumin binding proteins |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028872 Human monoclonal antibodies to cd70 |
| 01/29/2009 | US20090028869 Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028854 sc(Fv)2 SITE-DIRECTED MUTANT |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028850 Prolongation of survival of an allograft by inhibiting complement activity |
| 01/29/2009 | US20090028848 Sequence based engineering and optimization of single chain antibodies |
| 01/29/2009 | US20090028843 IgA allelic variants |
| 01/29/2009 | US20090028842 Dekkera/Brettanomyces Cytosine Deaminases And Their Use |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | US20090028789 Methods for detecting parenchymal plaques in vivo |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2720628A1 Fusion proteins |
| 01/29/2009 | CA2697159A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694397A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694121A1 Methods and compositions for treating autoimmune disease |
| 01/29/2009 | CA2694001A1 Complexes of grp94 with human immunoglobulin g |
| 01/29/2009 | CA2693305A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | CA2693277A1 Immune modulation via c-type lectin |
| 01/29/2009 | CA2692006A1 Materials and methods for sperm sex selection |
| 01/29/2009 | CA2691218A1 An antigen associated with lung cancers and lymphomas |
| 01/28/2009 | EP2019148A1 Gene mapping method using microsatellite genetic polymorphism markers |
| 01/28/2009 | EP2019139A1 WT1 interacting protein WTIP |
| 01/28/2009 | EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018399A1 Anti-2-o-desulfated acharan sulfate antibody and its application |
| 01/28/2009 | EP2018398A1 Anti-acharan sulfate antibody and its application |